CytoMed Therapeutics

GDTC

NASDAQHealth Care

Income Statement

Total Revenue$0

Operating Income$0

EBITDA$0

EBIT$-7.85M

Pre-tax Income$-7.35M

Net Income$-7.36M

Net Cash$64.72M

Cash Equivalent$6.47M

Total Debt$430K

Net Debt$-64.29M

Book Value$10.88

Net Cash Per Share5390000.00

Book Value Per Share0.91

Return on Equity (ROE)-37.55%

Return on Assets (ROA)-34.42%

Return on Invested Capital (ROI)-36.07%

Net Profit Marginundefined

Current Ratio13.89

Quick Ratio12.72

Long-Term Debt / Equity0.04